Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti-PD-1 mAb treated recurrent/metastatic squamous cell carcinoma of the head and neck patients.

Saved in:
Bibliographic Details
Title: Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti-PD-1 mAb treated recurrent/metastatic squamous cell carcinoma of the head and neck patients.
Authors: Zandberg DP; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Zenkin S; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Ak M; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Mamindla P; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Peddagangireddy V; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Hsieh R; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Anderson JL; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Delgoffe GM; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Menk A; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Skinner HD; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Duvvuri U; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Ferris RL; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Colen RR; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Source: Head & neck [Head Neck] 2025 Jan; Vol. 47 (1), pp. 129-138. Date of Electronic Publication: 2024 Jul 30.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: John Wiley And Sons Country of Publication: United States NLM ID: 8902541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0347 (Electronic) Linking ISSN: 10433074 NLM ISO Abbreviation: Head Neck Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1097-0347
DOI:10.1002/hed.27878